# Avadel Legacy Pharmaceuticals LLC, Chesterfield, MO – FDA Inspections

Source: https://www.keypedia.com/companies/avadel-legacy-pharmaceuticals-llc/b4511df8-4278-4924-9a28-a3600d1fdc71

> Inspection records and compliance data for Avadel Legacy Pharmaceuticals LLC in Chesterfield, Missouri. 8 FDA inspections on record (1 OAI), 1 Form 483, last inspected April 24, 2019.

---

## Details

- Name: Avadel Legacy Pharmaceuticals LLC
- FEI Number: 3008832322
- Address Line 1: 16640 Chesterfield Grove Rd Ste 200
- City: Chesterfield
- State: Missouri
- Zip Code: 63005
- Country Name: United States
- Address: 16640 Chesterfield Grove Rd Ste 200, Chesterfield, Missouri 63005, United States
- Country: United States

## Related Documents

- FDA Inspection 1091059 - Avadel Legacy Pharmaceuticals LLC - 2019-04-24 — classification: No Action Indicated (NAI), source: FDA, date: April 24, 2019
- FDA Inspection 1068774 - Avadel Legacy Pharmaceuticals LLC - 2018-10-11 — classification: No Action Indicated (NAI), source: FDA, date: October 11, 2018
- FDA Inspection 1027967 - Avadel Legacy Pharmaceuticals LLC - 2017-10-06 — classification: No Action Indicated (NAI), source: FDA, date: October 6, 2017
- [FDA Inspection 1027967 - Avadel Legacy Pharmaceuticals LLC - 2017-10-06](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/ef4e5ca0-ac2b-488b-8b2b-fc90c7521427) — classification: No Action Indicated (NAI), source: FDA, date: October 6, 2017
- FDA Inspection 1027967 - Avadel Legacy Pharmaceuticals LLC - 2017-10-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 6, 2017
- [FDA Inspection 946968 - Avadel Legacy Pharmaceuticals LLC - 2015-09-23](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/4d1c3786-cba8-4f1a-9d8e-be287153e030) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 23, 2015
- FDA Inspection 859453 - Avadel Legacy Pharmaceuticals LLC - 2013-12-09 — classification: No Action Indicated (NAI), source: FDA, date: December 9, 2013
- FDA Inspection 762688 - Avadel Legacy Pharmaceuticals LLC - 2011-11-02 — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2011
- FDA Inspection 762688 - Avadel Legacy Pharmaceuticals LLC - 2011-11-02 — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2011
- FDA Inspection 762688 - Avadel Legacy Pharmaceuticals LLC - 2011-11-02 — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2011

## Related Companies

- [Atrion Medical Products Inc](https://www.keypedia.com/companies/atrion-medical-products-inc/23b198ee-391f-4d44-8db4-42b45ebfa906)
- [Scripps IRB](https://www.keypedia.com/companies/scripps-irb/249b946b-a5f3-491f-b6ce-4f2c21a578da)
- [Texas Health Resources IRB](https://www.keypedia.com/companies/texas-health-resources-irb/14bcffc9-113a-4fcf-8e13-956ea7cd23a7)
- [MEDLINE INDUSTRIES, LP - SPT](https://www.keypedia.com/companies/medline-industries-lp-spt/7ca60e30-c209-4949-b8e5-15f4c78ffc49)
- [David J. Goldberg, MD](https://www.keypedia.com/companies/david-j-goldberg-md/cf521521-d3ea-4381-811e-d7c9fb0634c3)
- [Mercer University IRB](https://www.keypedia.com/companies/mercer-university-irb/77ceda76-8fd7-4698-82f1-5413eeaea95a)
- [Sekisui Diagnostics LLC](https://www.keypedia.com/companies/sekisui-diagnostics-llc/c3fa7f62-9334-4da7-ba62-e7f2e1aa00e9)
- [Dentsply Sirona Preventive](https://www.keypedia.com/companies/dentsply-sirona-preventive/eeaa4545-7747-4d6d-a055-81e840c54b58)
- [David E. Bank, M.D.](https://www.keypedia.com/companies/david-e-bank-md/e133a6e1-90a7-4120-83a7-f00d7cf9dd0e)
- [Lowell General Hospital/IRB](https://www.keypedia.com/companies/lowell-general-hospitalirb/de71969e-2d0a-4c39-bd76-902cec07e16e)